ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO197

A Signaling Module Linking DJ-1, PTEN, and PDGF Receptor β (PDGFR) Governs Activation of mTORC1 to Induce Proximal Tubular Epithelial Cell (PTEC) Injury in Diabetic Nephropathy (DN)

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • Das, Falguni, UTHSCSA, San Antonio, Texas, United States
  • Ghosh-choudhury, Nandini, UTHSCSA, San Antonio, Texas, United States
  • Kasinath, Balakuntalam S., UTHSCSA, San Antonio, Texas, United States
  • Ghosh-Choudhury, Goutam, UTHSCSA, San Antonio, Texas, United States
Background

PTEN inactivation and PDGFR tyrosine kinase-mediated mTORC1 activation have emerged as the centerpiece in pathogenesis of DN and tumorigenesis. The familial Parkinson’s disease protein DJ-1 causes cancer. We investigated the hypothesis that DJ-1 acts as a driver of PDGFR-mediated mTORC1 activation in the progression of DN.

Methods

Human PTECs, OVE26 and db/db mice, and activation-specific antibodies, immunoblotting, plasmid-derived expression vector, siRNAs and promoter-reporter transfections were employed.

Results

In PTECs, 25 mM glucose (HG) increased expression of DJ-1. In determining its role in PTEC pathology, we showed that siRNAs against DJ-1 inhibited HG-induced PTEC hypertrophy and fibronectin and collagen I (α2) protein expression and their transcription, while forced expression of FLAG-DJ-1 increased these phenomena. As Akt/mTORC1 signaling regulates these effects of HG, we tested involvement of DJ-1. siDJ-1 inhibited HG-stimulated phosphorylation of Akt, its substrates GSK3β, tuberin and PRAS40, and phosphorylation of S6 kinase, 4EBP-1 and mTOR. In contrast, FLAG-DJ-1 increased these phosphorylation events similar to HG. We have shown previously that HG-stimulated PTEC injury requires PDGFR stimulation of mTORC1 activity. Crucially, we showed that siDJ-1 decreased HG-stimulated phosphorylation of PDGFR at its docking sites of PI 3 kinase, whose function is known to be inactivated by PTEN, a dual specificity tyrosine and lipid phosphatase. Furthermore, we showed that HG increased association of DJ-1 with PTEN. We hypothesized that DJ-1-bound and inactivated PTEN lead to PDGFR phosphorylation. Interestingly, we showed that plasmid-derived expression of PTEN decreased HG-induced tyrosine phosphorylation of PDGFR and its substrate PI 3 kinase. In addressing the in vivo relevance of our results, in the renal cortex of OVE26 and db/db mice models of type 1 and type 2 diabetes, we found increased expression of DJ-1, PDGFR phosphorylation, mTORC1 activation and fibronectin and collagen I (α2) expression.

Conclusion

Together our results uncover a novel three layered molecular circuitry where PDGFR serves as a substrate of PTEN that is quenched by DJ-1 in PTEC injury in DN.

Funding

  • Veterans Affairs Support